Gro Biosciences
Cambridge, US · Founded 2016 · Delaware corporation · 4 known investors
Biotech
Founders & leadership
DJ
Daniel J MandellExecutive Officer, Director
TL
Tracey LodieExecutive Officer
CG
Christopher GreggDirector
GS
Geoffrey SmithDirector
MF
Ming FangDirector
BB
Bruce BeutelDirector
DB
Dan BeckerDirector
KB
Kevin BittermanDirector
RD
Rakhshita DharDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$27.4MraisedJul 2024 · 13 investors · Other TechnologyRule 506(b)
▶$27.4MraisedJul 2024 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ming FangDirector
- Bruce BeutelDirector
- Dan BeckerDirector
- Tracey LodieExecutive Officer
- Kevin BittermanDirector
- Daniel J MandellExecutive Officer, Director
- Rakhshita DharDirector
- Offering amount
- $60.4M
- Amount sold
- $27.4M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedMar 2019 · 10 investors · BiotechnologyRule 506(b)
▶$3.7MraisedMar 2019 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel MandellExecutive Officer, Director
- Geoffrey SmithDirector
- Christopher GreggDirector
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$2.1MraisedSep 2017 · 8 investors · BiotechnologyRule 506(b)
▶$2.1MraisedSep 2017 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel J MandellExecutive Officer, Director
- Christopher GreggDirector
- Geoffrey SmithDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.